These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 21737949)

  • 1. Beta-blocker therapy for patients with acute myocardial infarction. -Implications in the post-successful PCI Era in Japan-.
    Seino Y
    Circ J; 2011; 75(8):1829-30. PubMed ID: 21737949
    [No Abstract]   [Full Text] [Related]  

  • 2. Additive effects of β-blockers on renin-angiotensin system inhibitors for patients after acute myocardial infarction treated with primary coronary revascularization.
    Konishi M; Haraguchi G; Yoshikawa S; Kimura S; Inagaki H; Isobe M
    Circ J; 2011; 75(8):1982-91. PubMed ID: 21697605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-blocker treatment before angiotensin-converting enzyme inhibitor therapy in newly diagnosed heart failure.
    Willenheimer R; van Veldhuisen DJ; Ponikowski P; Lechat P;
    J Am Coll Cardiol; 2005 Jul; 46(1):182. PubMed ID: 15992659
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of low doses of metoprolol, bisoprolol and carvedilol on mortality in patients with left ventricular dysfunction after acute myocardial infarction].
    Ruta J; Ptaszyński P; Maciejewski M; Goch JH; Chizyński K
    Wiad Lek; 2006; 59(9-10):649-53. PubMed ID: 17338123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of single or dual blockade of renin-angiotensin system in acute myocardial infarction patients according to renal function.
    Jeong HC; Jeong JM; Jeong MH; Ahn Y; Chae SC; Hur SH; Hong TJ; Kim YJ; Seong IW; Chae JK; Rhew JY; Chae IH; Cho MC; Bae JH; Rha SW; Kim CJ; Choi D; Jang YS; Yoon J; Chung WS; Cho JG; Seung KB; Park SJ;
    Int J Cardiol; 2012 Jun; 157(3):408-11. PubMed ID: 22513185
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of synergistic effects of resynchronization therapy and a β-blocker up-titration strategy based on a predefined patient-management program: the RESTORE study.
    Palmisano P; Ammendola E; D'Onofrio A; Accogli M; Calò L; Ruocco A; Rapacciuolo A; Del Giorno G; Bianchi V; Malacrida M; Valsecchi S; Gronda E
    Clin Cardiol; 2015 Jan; 38(1):2-7. PubMed ID: 25580847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional differences among female patients with heart failure from the Cardiac Insufficiency BIsoprolol Study in ELDerly (CIBIS-ELD).
    Apostolovic S; Stanojevic D; Lainscak M; Gelbrich G; Jankovic-Tomasevic R; Pavlovic M; Djordjevic-Radojkovic D; Salinger-Martinovic S; Putnikovic B; Radovanovic S; Waagstein F; Tomasevic M; Tahirovic E; Inkrot S; Musial-Bright L; Düngen HD
    Cardiol J; 2014; 21(3):265-72. PubMed ID: 23990195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function.
    Law Y
    J Am Coll Cardiol; 2005 Jul; 46(1):181-2; author reply 183. PubMed ID: 15992657
    [No Abstract]   [Full Text] [Related]  

  • 9. [Efficacy of ramipril, carvedilol, and trimetazidine MR in improvement of quality of life of patients after myocardial infarction].
    Gafurova RM; Abdullaev AA; Kadieva IA; Islamova UA; Mutalipov KhM
    Kardiologiia; 2010; 50(12):15-8. PubMed ID: 21591386
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of Carvedilol versus β1-selective β blockers (bisoprolol, metoprolol, and nebivolol) in patients with acute myocardial infarction undergoing percutaneous coronary intervention.
    Seo GW; Kim DK; Kim KH; Seol SH; Jin HY; Yang TH; Ahn Y; Jeong MH; Song PS; Kim DI;
    Am J Cardiol; 2015 Nov; 116(10):1502-8. PubMed ID: 26520013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of carvedilol and metoprolol in patients with acute myocardial infarction undergoing primary coronary intervention--the PASSAT Study.
    Tölg R; Witt M; Schwarz B; Kurz T; Kurowski V; Hartmann F; Geist V; Richardt G
    Clin Res Cardiol; 2006 Jan; 95(1):31-41. PubMed ID: 16598443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiparametric comparison of CARvedilol, vs. NEbivolol, vs. BIsoprolol in moderate heart failure: the CARNEBI trial.
    Contini M; Apostolo A; Cattadori G; Paolillo S; Iorio A; Bertella E; Salvioni E; Alimento M; Farina S; Palermo P; Loguercio M; Mantegazza V; Karsten M; Sciomer S; Magrì D; Fiorentini C; Agostoni P
    Int J Cardiol; 2013 Oct; 168(3):2134-40. PubMed ID: 23506636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisoprolol and heart failure: new frontiers.
    Chopra HK
    Indian Heart J; 2010; 62(1):7-12. PubMed ID: 21180027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the β1-adrenoceptor Arg389Gly polymorphism on heart-rate responses to bisoprolol and carvedilol in heart-failure patients.
    Rau T; Düngen HD; Edelmann F; Waagstein F; Lainščak M; Dimković S; Apostolović S; Nešković AN; Haverkamp W; Gelbrich G; Eschenhagen T
    Clin Pharmacol Ther; 2012 Jul; 92(1):21-8. PubMed ID: 22617224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined use of direct renin inhibitor and carvedilol in heart failure with preserved systolic function.
    Badheka AO; Tuliani TA; Rathod A; Ali Kizilbash M; Bharadwaj A; Afonso L
    Med Hypotheses; 2012 Oct; 79(4):448-51. PubMed ID: 22800805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension - study protocol for a randomized controlled trial.
    Cestário EDES; Fernandes LAB; Giollo-Júnior LT; Uyemura JRR; Matarucco CSS; Landim MIP; Cosenso-Martin LN; Tácito LHB; Moreno H; Vilela-Martin JF; Yugar-Toledo JC
    Trials; 2018 Feb; 19(1):101. PubMed ID: 29433578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The comparative effects of long-term carvedilol versus bisoprolol therapy on QT dispersion in patients with chronic heart failure.
    Aygul N; Ozdemir K; Duzenli MA; Aygul MU
    Cardiology; 2009; 112(3):168-73. PubMed ID: 18654081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effects of carvedilol as a concomitant therapy to angiotensin-converting enzyme inhibitor in patients with ischemic left ventricular systolic dysfunction.
    Gandhi PS; Goyal RK; Jain AR; Mallya BS; Gupta VM; Shah DS; Trivedi BR; Shastri NA; Mehta CB; Jain KA; Bhavasar NS; Shah UJ
    Can J Physiol Pharmacol; 2007 Feb; 85(2):193-9. PubMed ID: 17487260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of beta blockade (carvedilol or metoprolol) on activation of the renin-angiotensin-aldosterone system and natriuretic peptides in chronic heart failure.
    Fung JW; Yu CM; Yip G; Chan S; Yandle TG; Richards AM; Nicholls MG; Sanderson JE
    Am J Cardiol; 2003 Aug; 92(4):406-10. PubMed ID: 12914870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correction of baroreflex sensitivity impairment and efficacy of prevention of sudden arrhythmic death in patients with postinfarction left ventricular dysfunction].
    Kanopskiĭ SG; Staritskiĭ AG; Bozhko AA
    Kardiologiia; 2004; 44(10):13-8. PubMed ID: 15477784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.